Cargando…

How to Treat HR+/HER2- Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story

CDK4/6 inhibitors in association with endocrine therapy represent the best therapeutic choice for either endocrine-sensitive or resistant hormone-receptor-positive advanced breast cancer patients. On the contrary, the optimal therapeutic strategy after the failure of CDK4/6 inhibitors-based treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cogliati, Viola, Capici, Serena, Pepe, Francesca Fulvia, di Mauro, Pierluigi, Riva, Francesca, Cicchiello, Federica, Maggioni, Claudia, Cordani, Nicoletta, Cerrito, Maria Grazia, Cazzaniga, Marina Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954717/ https://www.ncbi.nlm.nih.gov/pubmed/35330128 http://dx.doi.org/10.3390/life12030378

Ejemplares similares

Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study
por: Pepe, F. F., et al.
Publicado: (2022)

Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows
por: Cazzaniga, Marina Elena, et al.
Publicado: (2022)

Metronomic Chemotherapy
por: Cazzaniga, Marina Elena, et al.
Publicado: (2021)

Comparison of tumor microenvironment in primary and paired metastatic ER+/HER2- breast cancers: results of a pilot study
por: Zeppellini, Annalisa, et al.
Publicado: (2021)

Personalised Therapies for Metastatic Triple-Negative Breast Cancer: When Target Is Not Everything
por: Capici, Serena, et al.
Publicado: (2022)

An unfinished story : gender patterns in media employment
por: Gallegher, Margaret
Publicado: (1995)

The Human Transcriptome: An Unfinished Story
por: Pertea, Mihaela
Publicado: (2012)

Humidifier disinfectants, unfinished stories
por: Choi, Yeyong, et al.
Publicado: (2016)

Covid-19, an unfinished story
por: Buisson, Yves
Publicado: (2022)

TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells
por: Cordani, Nicoletta, et al.
Publicado: (2023)

Viral hepatitis in Saudi Arabia: An unfinished story
por: Abdo, Ayman A., et al.
Publicado: (2015)

Mobilizing Against AIDS: The Unfinished Story of a Virus
por: Jekel, James F.
Publicado: (1987)

John squire and endothelial glycocalyx structure: an unfinished story
por: Arkill, Kenton P., et al.
Publicado: (2022)

SARS-CoV-2 variants, a still unfinished story()
por: Pérez-Abeledo, M., et al.
Publicado: (2021)

Epidemiology and Control of Meningococcal Disease in Canada: A Long, Complex, and Unfinished Story
por: De Wals, Philippe
Publicado: (2019)

Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors
por: Zattarin, Emma, et al.
Publicado: (2023)

The unfinished society.
por: Borch, Herbert von
Publicado: (1963)

The unfinished war
por: Martelletti, Paolo
Publicado: (2002)

The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment?
por: Dauby, Nicolas, et al.
Publicado: (2021)

Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2− advanced breast cancer
por: Corona, Silvia Paola, et al.
Publicado: (2018)

QCD: An Unfinished Symphony
por: Wilczek, F
Publicado: (2012)

Bias, the unfinished symphony
por: Coşkun, Abdurrahman
Publicado: (2022)

CDK 4/6 inhibitors mired in uncertainty in HR positive and HER2 negative early breast cancer
por: Di Cosimo, Serena, et al.
Publicado: (2020)

Einstein's unfinished symphony: the story of a gamble, two black holes, and a new age of astronomy
por: Bartusiak, Marcia
Publicado: (2017)

Immune effects of CDK4/6 inhibitors in patients with HR(+)/HER2(−) metastatic breast cancer: Relief from immunosuppression is associated with clinical response
por: Scirocchi, Fabio, et al.
Publicado: (2022)

Symphony in B minor (Unfinished)
por: Chusid, Martin

Starting Afresh: An Unfinished History
por: Tonkin, G. P.
Publicado: (1968)

President’s Message: Unfinished Business
por: Brooks, Oliver T.
Publicado: (2020)

COVID-19 and Unfinished Mourning
por: Farahmandnia, Behnam, et al.
Publicado: (2020)

The unfinished revolution : learning, human behavior, community and political paradox
por: Abbott, John, 1939-
Publicado: (2001)

HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles
por: Sammons, Sarah L., et al.
Publicado: (2017)

Are We Prepared for the CDK4/6 Revolution With HR+/HER2− Breast Cancers?: The Importance of Patient Adherence to Adjuvant Therapies
por: Azoz, Seyla, et al.
Publicado: (2023)

About time: Einstein’s unfinished revolution
por: Davies, Paul
Publicado: (1995)

Cochrane: the unfinished symphony of research synthesis
por: Roberts, Ian, et al.
Publicado: (2016)

Global Health Security—An Unfinished Journey
por: Osterholm, Michael T.
Publicado: (2017)

Unfinished business - Leprosy still not defeated
por: Scollard, David M.
Publicado: (2019)

Community-Acquired Pneumonia: An Unfinished Battle
por: Nair, Girish B., et al.
Publicado: (2011)

Real-World Experience with CDK4/6 Inhibitors for Metastatic HR+/HER2− Breast Cancer at a Single Cancer Center
por: Knudsen, Erik S, et al.
Publicado: (2022)

Agrarian reform as unfinished business : the selected papers of Wolf Ladejinsky /
por: Ladejinsky, Wolf Isaac
Publicado: (1977)

Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2− Metastatic Breast Cancer
por: Zhao, Joseph J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ml1oc3lipfugn03klfvp3rhruc